Clyburn Frank
SEC insider (Form 3/4/5 filer). CIK 0001763963. Director at Revolution Medicines, Inc. (RVMD) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in CONSHOHOCKEN, PA.
Companies Clyburn Frank has filed insider reports for
- Revolution Medicines, Inc. (RVMD): Director
- Kailera Therapeutics, Inc. (KLRA): Director
- Cencora, Inc. (COR): Director
Clyburn Frank
CIK: 0001763963
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 18, 2026RVMD
Revolution Medicines, Inc.
AwardDirect1.2K shares- - Apr 16, 2026KLRA
Kailera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
38.3K shares- - Mar 5, 2026COR
Cencora, Inc.
AwardDirect557 shares at avg. $359.28$200K - Jun 26, 2025RVMD
Revolution Medicines, Inc.
AwardDirect2.8K shares- - Mar 11, 2025COR
Cencora, Inc.
Small AcquisitionDirect4 shares at avg. $260.69$1K - Mar 6, 2025COR
Cencora, Inc.
AwardDirect789 shares- - Nov 1, 2024COR
Cencora, Inc.
AwardDirect368 shares at avg. $234.27$86K - Aug 5, 2024RVMD
Revolution Medicines, Inc.
AwardDirectStock Option (Right to Buy)
26.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  RVMD Revolution Medicines, Inc. | Award | 1,191 | - | $0 | Direct |
| Apr 16, 2026 |  KLRA Kailera Therapeutics, Inc. | Award Stock Option (right to buy) | 38,300 | - | - | Direct |
| Mar 5, 2026 |  COR Cencora, Inc. | Award | 557 | $359.28 | $200,119 | Direct |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | Award | 2,806 | - | - | Direct |
| Mar 11, 2025 | COR Cencora, Inc. | Small Acquisition | 4 | $260.69 | $1,043 | Direct |
| Mar 6, 2025 | COR Cencora, Inc. | Award | 789 | - | - | Direct |
| Nov 1, 2024 | COR Cencora, Inc. | Award | 368 | $234.27 | $86,211 | Direct |
| Aug 5, 2024 | RVMD Revolution Medicines, Inc. | Award Stock Option (Right to Buy) | 26,540 | - | - | Direct |
1-8 of 8 transactions